Director Christopher Gibson of Recursion Pharmaceuticals NASDAQ:RXRX, sold 40,000 shares of Class A Common Stock on January 5, 2026, at a price of $4.25, totaling $170,000. The transaction occurred as ...
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Wondering if Recursion ...
Hosted on MSN
Recursion Pharmaceuticals projects $100M synergies in 2025 amid advancing pipeline and partnerships
CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...
Condé Nast Traveler on MSN
The best city in the US for shopping is exactly the one you think it is
Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results